Literature DB >> 34138546

Deciphering Antifungal Drug Resistance in Pneumocystis jirovecii DHFR with Molecular Dynamics and Machine Learning.

Florian Leidner1, Nese Kurt Yilmaz1, Celia A Schiffer1.   

Abstract

Drug resistance impacts the effectiveness of many new therapeutics. Mutations in the therapeutic target confer resistance; however, deciphering which mutations, often remote from the enzyme active site, drive resistance is challenging. In a series of Pneumocystis jirovecii dihydrofolate reductase variants, we elucidate which interactions are key bellwethers to confer resistance to trimethoprim using homology modeling, molecular dynamics, and machine learning. Six molecular features involving mainly residues that did not vary were the best indicators of resistance.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34138546      PMCID: PMC9109225          DOI: 10.1021/acs.jcim.1c00403

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   6.162


  8 in total

Review 1.  Thymine metabolism and thymineless death in prokaryotes and eukaryotes.

Authors:  S I Ahmad; S H Kirk; A Eisenstark
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

2.  Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target.

Authors:  Yongyuth Yuthavong; Bongkoch Tarnchompoo; Tirayut Vilaivan; Penchit Chitnumsub; Sumalee Kamchonwongpaisan; Susan A Charman; Danielle N McLennan; Karen L White; Livia Vivas; Emily Bongard; Chawanee Thongphanchang; Supannee Taweechai; Jarunee Vanichtanankul; Roonglawan Rattanajak; Uthai Arwon; Pascal Fantauzzi; Jirundon Yuvaniyama; William N Charman; David Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

3.  Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates.

Authors:  Michael N Lombardo; Narendran G-Dayanandan; Dennis L Wright; Amy C Anderson
Journal:  ACS Infect Dis       Date:  2016-01-04       Impact factor: 5.084

4.  Trimethoprim resistance of dihydrofolate reductase variants from clinical isolates of Pneumocystis jirovecii.

Authors:  S F Queener; V Cody; J Pace; P Torkelson; A Gangjee
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

5.  The structure of Pneumocystis carinii dihydrofolate reductase to 1.9 A resolution.

Authors:  J N Champness; A Achari; S P Ballantine; P K Bryant; C J Delves; D K Stammers
Journal:  Structure       Date:  1994-10-15       Impact factor: 5.006

6.  High-Order Epistasis in Catalytic Power of Dihydrofolate Reductase Gives Rise to a Rugged Fitness Landscape in the Presence of Trimethoprim Selection.

Authors:  Yusuf Talha Tamer; Ilona K Gaszek; Haleh Abdizadeh; Tugce Altinusak Batur; Kimberly A Reynolds; Ali Rana Atilgan; Canan Atilgan; Erdal Toprak
Journal:  Mol Biol Evol       Date:  2019-07-01       Impact factor: 16.240

Review 7.  Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors.

Authors:  Agnieszka Wróbel; Karolina Arciszewska; Dawid Maliszewski; Danuta Drozdowska
Journal:  J Antibiot (Tokyo)       Date:  2019-10-02       Impact factor: 2.649

8.  Characterization of trimethoprim resistant E. coli dihydrofolate reductase mutants by mass spectrometry and inhibition by propargyl-linked antifolates.

Authors:  Michael Cammarata; Ross Thyer; Michael Lombardo; Amy Anderson; Dennis Wright; Andrew Ellington; Jennifer S Brodbelt
Journal:  Chem Sci       Date:  2017-03-28       Impact factor: 9.825

  8 in total
  1 in total

1.  General Equation to Express Changes in the Physicochemical Properties of Organic Homologues.

Authors:  Chao-Tun Cao; Chenzhong Cao
Journal:  ACS Omega       Date:  2022-07-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.